4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-019757
Chief Executive Officer bought 1,160 shares at $6.89 ($7,987)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-14 | Purchase : show line 1 in the form | +1,160 | $6.89 | $7,987 | 59,935 | D |
| Open-market purchases · 1,160 sh · avg $6.89 · $7,987 | ||||||
Loading xslF345X03/doc4.xml…